Skip to content
MARKETS / NASDAQ / WGS
NASDAQ · SERVICES-HEALTH SERVICES · LARGE CAP

GeneDx Holdings Corp. WGS

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$427.5M
▲ 40.0% YoY
$-21.0M
$14.3M
Growth
USD 427.5M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 427.5 · Net income -21.0
200M400M-200M-400M2019202020212022202320242025
Compound annual growth
+22.1%
+19.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +19.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−5 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -3.1% · Net -4.9%
-100%-200%2019202020212022202320242025
ROE
FY2025 · ROE -7.6%
-500%2019202020212022202320242025

Each USD of equity lost 8 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 14.3
-200M2019202020212022202320242025

Total assetsUSD 523.7M
EquityUSD 308.2M
CashUSD 105.0M
Gross debtUSD 52.7M
Net debtUSD -52.3M
Current ratio2.46×

The company holds more cash than debt.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B0.40.30.20.20.20.20.2
Operating income $B−0.0−0.0−0.2−0.7−0.4−0.2−0.0
EBITDA $B−0.0−0.0−0.2−0.6−0.4−0.2−0.0
Income tax $B−0.0−0.0−0.0−0.00.00.00.0
Net income $B−0.0−0.1−0.2−0.5−0.2−0.2−0.0
Free cash flow $B0.0−0.0−0.2−0.3−0.2−0.1−0.0
EPS, diluted $−0.73···−2.27−47036.00·
Dividend / sh $·······
Payout %·······
ROE %−7.6−22.1−73.0−171.1−845.4··
Shares out B0.030.030.030.01···

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 29 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 66 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image